European Journal of Cancer · 2007 · 161 citations · 15 references
MedicineCardiologyPharmacologyCardio-oncologyCell SignalingRadionuclide TherapyAnthracycline CardiotoxicityBiomarkers In Cardio-oncologyCancer Therapy-related CardiotoxicityCardiac BiomarkersCardiac PharmacotherapyHeart FailureAnthracycline-based ChemotherapyAnthracycline-induced CardiomyopathyAnthracycline-induced CardiotoxicityAnti-her2 Therapy CardiotoxicityBiomarkers Of Anthracycline CardiotoxicityBiomarkers Of Trastuzumab CardiotoxicityDoxorubicin Cardiotoxicity
15
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine Piccart, Marion Procter, Brian Leyland‐Jones et al. · New England Journal of Medicine · 2005 · 5.1K citations · Full text
Medicine, Oncology, Pharmacology +16
ErbB2 is essential in the prevention of dilated cardiomyopathy
Steven A. Crone, You‐Yang Zhao, Lian Fan et al. · Nature Medicine · 2002 · 918 citations